drugset / Trial / NCT00729807
0794GCC: Pentamidine in Treating Patients With Relapsed or Refractory Melanoma
Phase 2
Terminated
6 enrolled
University of Maryland, Baltimore
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy, such as pentamidine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well pentamidine works in treating patients with relapsed or refractory melanoma.
Timeline
- Start
- 2008-07
- Primary completion
- 2012-08
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pentamidine | Unknown | — | Intravenous |